Correlation Between DnB ASA and PCI Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DnB ASA and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DnB ASA and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DnB ASA and PCI Biotech Holding, you can compare the effects of market volatilities on DnB ASA and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DnB ASA with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of DnB ASA and PCI Biotech.

Diversification Opportunities for DnB ASA and PCI Biotech

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between DnB and PCI is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding DnB ASA and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and DnB ASA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DnB ASA are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of DnB ASA i.e., DnB ASA and PCI Biotech go up and down completely randomly.

Pair Corralation between DnB ASA and PCI Biotech

Assuming the 90 days trading horizon DnB ASA is expected to generate 1.67 times less return on investment than PCI Biotech. But when comparing it to its historical volatility, DnB ASA is 6.58 times less risky than PCI Biotech. It trades about 0.09 of its potential returns per unit of risk. PCI Biotech Holding is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  205.00  in PCI Biotech Holding on August 29, 2024 and sell it today you would lose (21.00) from holding PCI Biotech Holding or give up 10.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

DnB ASA  vs.  PCI Biotech Holding

 Performance 
       Timeline  
DnB ASA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in DnB ASA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental drivers, DnB ASA is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
PCI Biotech Holding 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in PCI Biotech Holding are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting essential indicators, PCI Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.

DnB ASA and PCI Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DnB ASA and PCI Biotech

The main advantage of trading using opposite DnB ASA and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DnB ASA position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.
The idea behind DnB ASA and PCI Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences